TRDMT1 Participates in the DNA Damage Repair of Granulosa Cells in Premature Ovarian Failure

2020 ◽  
Author(s):  
Chunli Sha ◽  
Lu Chen ◽  
Li Lin ◽  
Taoqiong Li ◽  
Hong Wei ◽  
...  
Keyword(s):  
Dna Damage ◽  
Granulosa Cells ◽  
Premature Ovarian Failure ◽  
Dna Damage Repair ◽  
Ovarian Failure ◽  
Damage Repair

scholarly journals TRDMT1 participates in the DNA damage repair of granulosa cells in premature ovarian failure

Aging ◽  
2021 ◽  
Author(s):  
Chunli Sha ◽  
Lu Chen ◽  
Li Lin ◽  
Taoqiong Li ◽  
Hong Wei ◽  
...  
Keyword(s):  
Dna Damage ◽  
Granulosa Cells ◽  
Premature Ovarian Failure ◽  
Dna Damage Repair ◽  
Ovarian Failure ◽  
Damage Repair

366-OR: TCF19 Promotes Functional Beta-Cell Mass and Proliferative Capacity by Regulating DNA Damage Repair Pathways

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 366-OR
Author(s):  
GRACE H. YANG ◽  
JEE YOUNG HAN ◽  
SUKANYA LODH ◽  
JOSEPH T. BLUMER ◽  
DANIELLE FONTAINE ◽  
...  
Keyword(s):  
Dna Damage ◽  
Beta Cell ◽  
Dna Damage Repair ◽  
Cell Mass ◽  
Beta Cell Mass ◽  
Proliferative Capacity ◽  
Damage Repair ◽  
Repair Pathways

DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review

2020 ◽  
Author(s):  
Nigel Armstrong ◽  
Ruben GW Quek ◽  
Steve Ryder ◽  
Janine Ross ◽  
Titas Buksnys ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
At Risk ◽  
Dna Damage ◽  
Clinical Trials ◽  
Genetic Counseling ◽  
Mutation Screening ◽  
Dna Damage Repair ◽  
Mutation Testing ◽  
Damage Repair

Background: Ongoing clinical trials are investigating poly(ADP-ribose) polymerase (PARP) inhibitors to target the DNA damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide treatment strategy and assess eligibility for clinical trials. Materials & methods: This systematic review estimated the rate of DDR mutation testing or genetic counseling among men with or at risk of prostate cancer. Results: From 6856 records, one study fulfilled the inclusion criteria and described men undiagnosed with prostate cancer with a family history of BRCA1/2 mutation who received DDR mutation testing. Conclusion: With only one study included in this first systematic review of DDR mutation testing or genetic counseling in men with or at risk of prostate cancer, more research is warranted.

Sign in / Sign up

Export Citation Format

Share Document